Matches in SemOpenAlex for { <https://semopenalex.org/work/W1605996956> ?p ?o ?g. }
- W1605996956 endingPage "1421" @default.
- W1605996956 startingPage "1406" @default.
- W1605996956 abstract "Imagine a medicine that is expected to have very limited effects based upon knowledge of its pharmacology and (patho)physiology and that is studied in the wrong population, with low‐quality studies that use a surrogate end‐point that relates to the clinical end‐point in a partial manner at most. Such a medicine would surely not be recommended. The use of recombinant human erythropoietin (rHuEPO) to enhance performance in cycling is very common. A qualitative systematic review of the available literature was performed to examine the evidence for the ergogenic properties of this drug, which is normally used to treat anaemia in chronic renal failure patients. The results of this literature search show that there is no scientific basis from which to conclude that rHuEPO has performance‐enhancing properties in elite cyclists. The reported studies have many shortcomings regarding translation of the results to professional cycling endurance performance. Additionally, the possibly harmful side‐effects have not been adequately researched for this population but appear to be worrying, at least. The use of rHuEPO in cycling is rife but scientifically unsupported by evidence, and its use in sports is medical malpractice. What its use would have been, if the involved team physicians had been trained in clinical pharmacology and had investigated this properly, remains a matter of speculation. A single well‐controlled trial in athletes in real‐life circumstances would give a better indication of the real advantages and risk factors of rHuEPO use, but it would be an oversimplification to suggest that this would eradicate its use." @default.
- W1605996956 created "2016-06-24" @default.
- W1605996956 creator A5025962515 @default.
- W1605996956 creator A5047227576 @default.
- W1605996956 creator A5050957661 @default.
- W1605996956 creator A5053899866 @default.
- W1605996956 creator A5054619577 @default.
- W1605996956 creator A5054688262 @default.
- W1605996956 creator A5080154142 @default.
- W1605996956 creator A5083164288 @default.
- W1605996956 date "2013-05-20" @default.
- W1605996956 modified "2023-10-17" @default.
- W1605996956 title "Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit" @default.
- W1605996956 cites W126815908 @default.
- W1605996956 cites W130692735 @default.
- W1605996956 cites W148611885 @default.
- W1605996956 cites W1493131411 @default.
- W1605996956 cites W1521333432 @default.
- W1605996956 cites W1564510779 @default.
- W1605996956 cites W1565541955 @default.
- W1605996956 cites W1573656797 @default.
- W1605996956 cites W1595400617 @default.
- W1605996956 cites W1604512090 @default.
- W1605996956 cites W170849090 @default.
- W1605996956 cites W170969310 @default.
- W1605996956 cites W1774553236 @default.
- W1605996956 cites W1793001825 @default.
- W1605996956 cites W187556099 @default.
- W1605996956 cites W1899050407 @default.
- W1605996956 cites W1926015747 @default.
- W1605996956 cites W1934068631 @default.
- W1605996956 cites W1948155231 @default.
- W1605996956 cites W1963516841 @default.
- W1605996956 cites W1963787884 @default.
- W1605996956 cites W1966621021 @default.
- W1605996956 cites W1967569804 @default.
- W1605996956 cites W1971217870 @default.
- W1605996956 cites W1972365033 @default.
- W1605996956 cites W1974845208 @default.
- W1605996956 cites W1975928628 @default.
- W1605996956 cites W1977017159 @default.
- W1605996956 cites W1977500450 @default.
- W1605996956 cites W1977574400 @default.
- W1605996956 cites W1980842970 @default.
- W1605996956 cites W1981401761 @default.
- W1605996956 cites W1984364277 @default.
- W1605996956 cites W1985569160 @default.
- W1605996956 cites W1987727256 @default.
- W1605996956 cites W1989820240 @default.
- W1605996956 cites W1990034536 @default.
- W1605996956 cites W1990059009 @default.
- W1605996956 cites W1990617364 @default.
- W1605996956 cites W1994875454 @default.
- W1605996956 cites W1995322594 @default.
- W1605996956 cites W1996273727 @default.
- W1605996956 cites W1996587449 @default.
- W1605996956 cites W1997259380 @default.
- W1605996956 cites W1999193165 @default.
- W1605996956 cites W1999692795 @default.
- W1605996956 cites W2005523155 @default.
- W1605996956 cites W2005579641 @default.
- W1605996956 cites W2009134055 @default.
- W1605996956 cites W2013995202 @default.
- W1605996956 cites W2014235011 @default.
- W1605996956 cites W2015336666 @default.
- W1605996956 cites W2017763561 @default.
- W1605996956 cites W2018547380 @default.
- W1605996956 cites W2019289959 @default.
- W1605996956 cites W2020834915 @default.
- W1605996956 cites W2022604215 @default.
- W1605996956 cites W2026357830 @default.
- W1605996956 cites W2026452824 @default.
- W1605996956 cites W2027661084 @default.
- W1605996956 cites W2033190206 @default.
- W1605996956 cites W2034881005 @default.
- W1605996956 cites W2036049894 @default.
- W1605996956 cites W2036684547 @default.
- W1605996956 cites W2038237410 @default.
- W1605996956 cites W2039026111 @default.
- W1605996956 cites W2039196629 @default.
- W1605996956 cites W2040313400 @default.
- W1605996956 cites W2042287547 @default.
- W1605996956 cites W2043265508 @default.
- W1605996956 cites W2047613719 @default.
- W1605996956 cites W2048749101 @default.
- W1605996956 cites W2051747076 @default.
- W1605996956 cites W2052271394 @default.
- W1605996956 cites W2053738179 @default.
- W1605996956 cites W2061776631 @default.
- W1605996956 cites W2067528536 @default.
- W1605996956 cites W2071467130 @default.
- W1605996956 cites W2072839085 @default.
- W1605996956 cites W2073822363 @default.
- W1605996956 cites W2074922229 @default.
- W1605996956 cites W2075641411 @default.
- W1605996956 cites W2077180506 @default.
- W1605996956 cites W2078999214 @default.
- W1605996956 cites W2080533286 @default.